Sitagliptin phosphate and Abnormal behavior - a phase IV clinical study of FDA data
Summary:
Abnormal behavior is reported as a side effect among people who take Sitagliptin phosphate (sitagliptin phosphate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Magnesium, and have Diabetes.
The phase IV clinical study analyzes which people have Abnormal behavior when taking Sitagliptin phosphate. It is created by eHealthMe based on reports of 3,765 people who have side effects when taking Sitagliptin phosphate from the FDA, and is updated regularly.
What is Sitagliptin phosphate?
Sitagliptin phosphate has active ingredients of sitagliptin phosphate. eHealthMe is studying from 3,787 Sitagliptin phosphate users. Check the latest studies of Sitagliptin phosphate.
What is Abnormal behavior?
Abnormal behavior is found to be associated with 1,365 drugs and 1,947 conditions by eHealthMe. Check the latest studies of Abnormal behavior.
3,765 people reported to have side effects when taking Sitagliptin phosphate.
Among them, 12 people (0.32%) have Abnormal behavior.

Among these 12 people:
How long have people been on Sitagliptin phosphate when they have Abnormal behavior? *
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Abnormal behavior when taking Sitagliptin phosphate? *
- female: 20 %
- male: 80 %
What is the age of people who have Abnormal behavior when taking Sitagliptin phosphate? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
What are other drugs people take besides Sitagliptin phosphate? *
- Magnesium: 5 people, 41.67%
- Vitamin D3: 4 people, 33.33%
- Zolpidem: 4 people, 33.33%
- Amaryl: 2 people, 16.67%
- Exelon: 2 people, 16.67%
- Paliperidone Palmitate: 2 people, 16.67%
- Metformin Hydrochloride: 2 people, 16.67%
- Metformin: 2 people, 16.67%
- Trulicity: 2 people, 16.67%
- Januvia: 2 people, 16.67%
What are other side effects people have besides Abnormal behavior? *
- Dyskinesia (abnormality or impairment of voluntary movement): 5 people, 41.67%
- Agitation (state of anxiety or nervous excitement): 3 people, 25.00%
- Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 3 people, 25.00%
- Muscle Rigidity (muscle stiffness): 2 people, 16.67%
- Altered State Of Consciousness (altered state of mind): 2 people, 16.67%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 16.67%
- Dehydration (dryness resulting from the removal of water): 2 people, 16.67%
- Delirium (wild excitement): 2 people, 16.67%
- Delusion (a false belief or opinion): 2 people, 16.67%
- Depressed Level Of Consciousness: 2 people, 16.67%
What are the existing conditions these people have? *
- Diabetes: 7 people, 58.33%
- Muscle Strain (an injury to a muscle in which the muscle fibres tear): 4 people, 33.33%
- Tardive Dyskinesia (a disorder that involves involuntary movements): 2 people, 16.67%
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 16.67%
- Psychotic Disorder: 2 people, 16.67%
- Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 2 people, 16.67%
- Type 2 Diabetes: 1 person, 8.33%
- Parkinson's Disease: 1 person, 8.33%
- Movement - Unpredictable Or Jerky: 1 person, 8.33%
- Ligament Sprain (ligament stretched): 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Sitagliptin phosphate and have Abnormal behavior?
- Check whether Abnormal behavior is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Sitagliptin phosphate:
- Sitagliptin phosphate (3,787 reports)
Abnormal behavior treatments and more:
- Abnormal behavior (51,307 reports)
How severe was Abnormal behavior and when was it recovered:
Expand to all the drugs that have ingredients of sitagliptin phosphate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sitagliptin phosphate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Abnormal behavior:
- Abnormal behavior (1,365 drugs)
Browse all the conditions that are associated with Abnormal behavior:
- Abnormal behavior (1,947 conditions)
Related publications that referenced our studies
- Liao KF, Lin CL, Lai SW, Chen WC, "Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: a population-based case-control study in Taiwan", European journal of internal medicine, 2016 Jan .
- Belice T, Yuce S, Kizilkaya B, Kurt A, Cure E, "Noncardiac pulmonary edema induced by sitagliptin treatment", Journal of family medicine and primary care, 2014 Jan .
- Misgar, R. A., Bhat, J. A., Wani, A. I., & Bashir, M. I., "Sitagliptin induced splenic infarcts", Clinical Diabetology, 2014 Jan .
- Stricklin SM, Stoecker WV, Rader RK, Hood AF, Litt JZ, Schuman TP, "Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia?)", Dermatology online journal, 2012 Feb .
- Liao KF, Lin CL, Lai SW, Chen WC, "Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: a population-based case-control study in Taiwan", European journal of internal medicine, 2016 Jan .
- Belice T, Yuce S, Kizilkaya B, Kurt A, Cure E, "Noncardiac pulmonary edema induced by sitagliptin treatment", Journal of family medicine and primary care, 2014 Jan .
- Misgar, R. A., Bhat, J. A., Wani, A. I., & Bashir, M. I., "Sitagliptin induced splenic infarcts", Clinical Diabetology, 2014 Jan .
- Stricklin SM, Stoecker WV, Rader RK, Hood AF, Litt JZ, Schuman TP, "Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia?)", Dermatology online journal, 2012 Feb .
How the study uses the data?
The study uses data from the FDA. It is based on sitagliptin phosphate (the active ingredients of Sitagliptin phosphate) and Sitagliptin phosphate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Endep vs. Fish Oil, side effect and effectiveness comparison - 5 seconds ago
- Could Namenda cause Appetite Decreased? - 7 seconds ago
- Could Namenda cause Appetite - Decreased? - 8 seconds ago
- Drug interactions of Periactin and Bactrim Ds - 20 seconds ago
- Could Profen cause Dactylitis? - 28 seconds ago
- Could Proleukin cause Hypotension? - 44 seconds ago
- Could Naproxen Sodium cause Red Blood Cell Sedimentation Rate Increased? - 59 seconds ago
- Could Irbesartan cause Meningitis? - 59 seconds ago
- Could Abiraterone Acetate cause Rickets? - a minute ago
- Type 2 Diabetes and Pneumocystis Jiroveci Pneumonia - a minute ago